Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
复制标题
DOI：
10.1016/s0735-1097(00)00804-4
复制
发表时间：
2000-09-01
影响因子：
24
通讯作者：
Wood, D
中科院分区：
文献类型：
--
作者：
Alpert, JS;Antman, E;Wood, D
总结...... 967 MI的定义...... 967参考书目...... 967病理学...... 967生物化学...... 967心电图...... 968成像系统968流行病学...... 968附录A...... 968附录B. 969附录C...... 969前言本文件由医学博士Kristian Thygesen和Joseph S. Alpert，医学博士，欧洲心脏病学会（ESC）主席Lars Ryden，医学博士和美国心脏病学会（ACC）主席亚瑟加尔森，医学博士正式批准后。所有与会者都是根据其所代表领域的专门知识挑选的，每个组织约有一半的与会者被选中。与会者被指示审查其专业领域的科学证据，并带着准备好的发言参加协商一致会议。该文件的初稿是在协商一致会议期间编写的。资金来源见附录A。本文件中提出的建议代表了与会者在会议召开时的态度和意见，这些建议随后进行了修订。随着新的科学证据的出现，所得出的结论无疑需要加以修订。本文件已由ESC科学和临床倡议委员会成员和ESC理事会成员审查，ESC理事会成员于2000年4月15日批准了本文件。
Summary...... 967Definition of MI...... 967Bibliography...... 967Pathology...... 967 Biochemistry...... 967 Electrocardiography...... 968 Imaging...... 968 Epidemiology...... 968Appendix A...... 968Appendix B...... 969Appendix C...... 969PreambleThis document was developed by a consensus conference initiated by Kristian Thygesen, MD, and Joseph S. Alpert, MD, after formal approval by Lars Rydén, MD, President of the European Society of Cardiology (ESC), and Arthur Garson, MD, President of the American College of Cardiology (ACC). All of the participants were selected for their expertise in the field they represented, with approximately one-half of the participants selected from each organization. Participants were instructed to review the scientific evidence in their area of expertise and to attend the consensus conference with prepared remarks. The first draft of the document was prepared during the consensus conference itself. Sources of funding appear in Appendix A. The recommendations made in this document represent the attitudes and opinions of the participants at the time of the conference, and these recommendations were revised subsequently. The conclusions reached will undoubtedly need to be revised as new scientific evidence becomes available. This document has been reviewed by members of the ESC Committee for Scientific and Clinical Initiatives and by members of the Board of the ESC who approved the document on April 15, 2000.∗∗